ZyCoV-D nears inclusion in vaccination drive as Centre orders 10 million doses | Latest News India - Hindustan Times
close_game
close_game

ZyCoV-D nears inclusion in vaccination drive as Centre orders 10 million doses

By, New Delhi
Nov 07, 2021 01:57 PM IST

According to reports, the indigenous, Zydus Cadila-developed jab is likely to be included this month, and will initially be administered only to adults.

Ahmedabad-based Zydus Cadila's ZyCoV-D, the country's second indigenous jab against the coronavirus disease (Covid-19), is likely to be included in the nationwide vaccination drive this month, with the Union government placing an order with the drug manufacturer for 10 million doses of the vaccine. Also, the needle-less jab, which received authorisation from the Drugs Controller General of India (DCGI) on August 20, will initially be administered only to adults, despite being the first vaccine to have been cleared for an age group below 18, being approved for inoculation of those aged 12 and above.

“The Centre has already placed a purchase order with Zydus Cadila for the supply of 1 crore doses of ZyCoV-D, with each dose costing 358 excluding taxes, at the earliest,” news agency PTI reported, quoting officials aware of the developments. 

Hindustan Times - your fastest source for breaking news! Read now.

Also Read | Zydus Cadila agrees to reduce price of each dose of its Covid-19 vaccine to 265

Explaining why only adults will be vaccinated initially, it said that this was because of the company's limited production capacity, adding that the firm has conveyed to the central government that it was in a position to deliver 10 million doses of ZyCoV-D, each month.

On September 30, Dr VK Paul, Niti Ayog's member (health) said that the world's first DNA-based vaccine would be used in the nationwide drive ‘very soon.’ Its regimen comprises three doses, which are to be administered on days 0, 28 and 56, respectively.

Also Read | Zydus Cadila Covid-19 jab soon to be part of India's vaccination programme: Govt

Till now, a total of six vaccines have received emergency use authorisation (EUA) from the drugs regulator, of which ZyCoV-D was the sixth. Hyderabad-based Bharat Biotech's Covaxin is the only other made-in-India jab cleared by the DCGI. Besides ZyCoV-D, it is also the only vaccine to have been recommended for kids, though it is yet to be approved by the regulator.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On